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Abstract
Intrathymic (i.t.) injection of allogenic cells without administration of anti-lymphocyte serum
(ALS) in neonatal recipients has induced donor-specific tolerance to subsequent cardiac allografts
in rats. This study examines whether similar tactics can be successfully applied to a hamster-to-rat
cardiac xenotransplantation model. Lewis neonates on their first day of life underwent i.t., sub-
cutaneous (s.c.), intraperitoneal (i.p.), or intravenous (i.v.) injections of 5 x 10(7) Golden Syrian
hamster splenocytes. After six weeks, the rats underwent heterotopic cardiac transplantation of
hamster hearts. Cyclophosphamide (CyP) was administered on the day before surgery and post-
operatively to suppress antibody-mediated graft rejection. Rats given splenocytes with 80 mg/kg
of CyP had the following graft survival times: 8 to 12 days for i.t. injection (mean, 9.4 days);
5 to 7 days for s.c. injection (mean, 6.6 days); 4 to 11 days for i.p. injection (mean, 7.4 days);
and 4 to 13 days for i.v. injection (mean, 7.9 days). Only the extension of graft survival produced
by i.t. injection was statistically significant in comparison with the rats given only CyP treatment
(mean, 7.5 days; P < 0.05). Thus, it appears that i.t. injection of xenogenic splenocytes in neona-
tal recipients with administration of CyP, but without ALS, can prolong xenograft survival. This
biological intervention may be most useful in pediatric xenotransplantation when combined with
other immunomodulation techniques.
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